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Abstract: Brushtail possums (Trichosurus vulpecula) present an ongoing threat to New Zealand’s environment 
and economy. Research into additional control techniques is vital to ensure that a variety of efficient tools are 
available to help achieve population suppression. Encapsulated sodium nitrite (NaNO2) has been developed in 
New Zealand as a new toxin for possum and feral pig (Sus scrofa) control. Its toxic effects at high doses are 
mediated through the induction of methaemoglobinaemia, a condition in which the carrying capacity of oxygen 
in red blood cells is reduced. This study investigated the potential secondary poisoning risks associated with 
NaNO2. Secondary poisoning risks were assessed for dogs, cats and chickens in small-scale trials. Trial groups 
for each species consisted of two treatment groups with four individuals per group and one non-treatment group 
with two individuals. For 6 consecutive days, the treatment groups of dogs, cats and chickens were fed entire or 
partial carcasses from possums lethally poisoned with paste bait containing encapsulated NaNO2. Individuals 
in each group were observed continuously for 3 hours following each daily feeding and blood samples were 
taken from dogs and cats. Individuals were observed for obvious physiological signs of NaNO2 poisoning and 
symptoms of methaemoglobinaemia specific to dogs, cats and chickens. None of the dogs, cats or chickens 
displayed any obvious physiological signs of poisoning or symptoms of methaemoglobinaemia. Blood chemistry 
and haematology parameters measured for dogs and cats were either within the range considered normal or when 
outside this range comparable levels were also recorded in the control group. No changes in histology relating 
to NaNO2 intoxication were observed in dogs or cats after being fed carcasses, minced meat, vital organs or 
stomachs of possums poisoned with NaNO2. Therefore, the secondary poisoning risk appears to be minimal.
Keywords: encapsulated sodium nitrite; methaemoglobinaemia; NaNO2; non-targets; secondary poisoning; 
Trichosurus vulpecula
Introduction
In New Zealand, the brushtail possum (Trichosurus vulpecula) 
is an ongoing threat to native flora and fauna, and threatens the 
primary sector as a vector of bovine tuberculosis (Coleman 
& Caley 2000; Cowan 2005). As a consequence, research 
continues to focus on potential new tools to assist with possum 
control strategies. Encapsulated sodium nitrite (NaNO2) in 
a paste bait was registered in New Zealand in 2013 by the 
Agricultural Compounds and Veterinary Medicines (ACVM) 
group for the control of brushtail possums and feral pigs (Sus 
scrofa). It has provided an effective addition to current control 
techniques for these two pest species (Shapiro et al. 2015, 2016).
NaNO2 is commonly used at low concentrations as a 
colour fixative and preservative in meats and fish (Binkerd 
& Kolari 1975; Epley et al. 1992). However, at higher doses 
NaNO2 can become toxic because of the effect it exerts on 
red blood cells. NaNO2 has the same mode of action as para-
aminopropiophenone (PAPP), a toxin registered for stoat and 
feral cat control in New Zealand in 2011 (Eason et al. 2014). 
Both compounds induce methaemoglobinaemia, a condition 
in which the carrying capacity of oxygen in red blood cells 
is reduced (Lee et al. 2013). In mammals, methaemoglobin 
(MtHb) levels in the blood are normally below 2% (Fan et al. 
1987). Levels of MtHb in the blood above 70% are usually 
fatal, creating a lethal deficit of oxygen in cardiac muscle and 
the brain, and the resulting rapid lack of oxygen to the brain 
and other vital organs quickly leads to death from respiratory 
failure (Wright et al. 1999; Eason et al. 2010). For mammals 
the common signs of severe methaemoglobinaemia include 
shortness of breath, cyanosis, lethargy, loss of consciousness 
and bluish colouring of the skin especially in areas of high 
blood supply like lips, gums, hands/paws and nose (Kennedy 
et al. 1997; Wright et al. 1999; Eason et al. 2014; Shapiro et 
al. 2015, 2016). In possums, death after a lethal dose usually 
occurs within 2 hours after bait has been consumed, with 
clinical signs first appearing within 15 to 35 minutes (Shapiro 
et al. 2016). Animals become lethargic and sleepy before they 
die and, at high doses, NaNO2 induces a relatively fast time 
to unconsciousness compared to most currently registered 
toxins (Shapiro et al. 2016). Encapsulated NaNO2 also has 
the benefit of an antidote (methylene blue).
Trials on possums and feral pigs with baits containing 
encapsulated NaNO2 have demonstrated high efficacy (>80%) 
(Shapiro et al. 2015, 2016). The effects from a lethal dose of 
bait are comparable to those previously observed on stoats, 
cats and foxes dosed with PAPP, a toxin that is also considered 
to be relatively more humane than currently registered toxins 
used for these species such as 1080 (Marks et al. 2004; 
Beausoleil et al. 2010; Eason et al. 2010, 2014; Murphy et al. 
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2011). However, possum control is often undertaken in close 
proximity to areas where domestic non-target species are 
present. An important attribute for toxins used in these areas 
is that they present a low risk of causing secondary poisoning. 
Therefore, this research investigated the associated risk of 
secondary poisoning to non-target species fed with carcasses 
of possums that had consumed a lethal dose of paste bait 
containing encapsulated NaNO2. 
Secondary poisoning, as defined by Ward (2008), occurs 
when a predator or scavenger consumes a prey item which 
has consumed a toxicant, thereby ingesting the toxicant and/or 
any toxic metabolites or residues. In monogastric animals like 
possums and pigs, most NaNO2 is absorbed in the upper part of 
the gastrointestinal tract and transferred to the blood (European 
Food Safety Authority 2009; Crowell et al. 2013). Nitrites are 
seldom found at detectable levels in tissues and bodily fluids 
following consumption and are unlikely to accumulate in 
tissues; it is hypothesised that this is due to the rapid oxidation 
of nitrite to nitrate and the rapid and extensive excretion of 
nitrite (Walker 1996; European Food Safety Authority 2009). 
The scientific literature on the pharmacokinetics (depletion 
rates) demonstrates that NaNO2 is rapidly excreted, with 
plasma elimination half-life values under 1 hour for numerous 
species of mammals (Schneider & Yeary 1975; Kohn et al. 
2002). This characteristic, coupled with NaNO2 being less 
toxic than most other vertebrate pesticides, could be viewed as 
being indicative of a low risk of secondary poisoning (Boink 
& Speijers 2001). However, sodium fluoroacetate (1080) is 
also excreted rapidly when compared to anticoagulants and 
yet has considerable secondary poisoning risk associated with 
its persistence in carcasses (Meenken & Booth 1997; Eason 
et al. 2012). 
While there is a great deal of data on the acute toxicity 
of NaNO2 (Winks et al. 1950; London et al. 1967; Sullivan 
1985; Cowled et al. 2008; Eason et al. 2009; Lapidge & Eason 
2010; Shapiro et al. 2015, 2016), very little data on the risk 
of secondary poisoning exists. Therefore, it is important to 
understand the potential risks, from carcasses of possums 
poisoned with NaNO2, to working farm dogs, livestock, pets 
and other non-target animals.
The purpose of this research was to determine the secondary 
poisoning risk for encapsulated NaNO2, by feeding carcasses of 
possums poisoned with baits containing NaNO2, to cats (Felis 
catus), dogs (Canis lupus familiaris) and chickens (Gallus 
gallus domesticus) for 6 days. Similar secondary poisoning 
studies have been undertaken during the evaluation of the 
suitability of other possum control tools, such as cholecalciferol 
and microencapsulated zinc phosphide (Henderson et al. 2003; 
Eason et al. 2013). Chickens were included in our study as 
a proxy for weka (Gallirallus australis), a flightless native 
bird known to scavenge carcasses and to have experienced 
varying degrees of mortality in previous 1080 operations 
(van Klink 2008). The similar body size, food preference 
and potential consumption rates of food make chickens an 
appropriate proxy for weka, which is why they have been 
routinely included in previous studies evaluating primary and 
secondary poisoning risk instead of native bird species (Eason 
et al. 2013). Dogs, cats and chickens fed these carcasses were 
exposed to concentrations of residues that would realistically 
be encountered by scavengers after poisoning operations. 
Materials and methods
Poisoning possums with NaNO2
Fifty-six brushtail possums were captured using live capture 
cage traps in Hororata, Canterbury, New Zealand. No vertebrate 
toxic agents had been used at this site for at least 6 months 
prior to possums being captured. Possums were transported to 
the Lincoln University Animal Facility, Lincoln, and housed 
individually in outdoor enclosures constructed of plywood 
and wire mesh and measuring 200 cm × 150 cm × 150 cm. 
Each cage had a hessian sack and wooden box for possums 
to use as a den. Possums were fed a selection of grains and 
fresh vegetables with water available ad libitum. Possums were 
acclimatised for 10 days and on three occasions in that period 
they were each pre-fed with approximately 50 g of a non-toxic 
paste bait consisting predominantly of grains and peanut butter. 
This formulation was the same as the toxic NaNO2 paste bait 
(but without the NaNO2) and this pre-feeding regime replicated 
common practice in control operations as well as the label 
recommendation for Bait-Rite paste (encapsulated NaNO2). 
Once acclimatised, possums were each presented with 
approximately 50 g of the paste bait, this time containing 10% 
NaNO2. This amount was selected due to its use in previous 
efficacy trials on possums outlined by Shapiro et al. (2016). 
The 50 g of paste bait consisted of 5 g (10%) of NaNO2, 0.26 g 
(0.5%) of encapsulant and 44.74 g (89.5%) of non-toxic paste. 
Groups of possums were poisoned in the week prior to the 
specific trial in which they were to be used. The paste bait used 
for killing possums was loaded with the same concentration 
of NaNO2 (10%) proven to kill possums in previous cage 
trials (Shapiro et al. 2016) and the same formulation that was 
registered for possum and feral pig control in New Zealand 
in 2013. Two samples of the encapsulated NaNO2 active 
(supplied by Connovation Ltd) were analysed by Flinders 
Cook Ltd (Auckland) to confirm the concentration of NaNO2 
active prior to the trial – the two samples were found to contain 
95% w/w NaNO2 active. The method of analysis was based 
on an internationally recognised analytical method described 
in Vogel (1979).
Once dead, possums were collected, placed in sacks and 
stored in a freezer at -10°C. Two possums were not frozen but 
instead were stored at room temperature for 2 days to enable 
tissue samples to be taken. A single sample of muscle, liver and 
stomach tissues was taken from both possums on days one and 
two, and these were sent to Flinders Cook Ltd (Auckland) to 
test for the presence of NaNO2 residues. The first sample was 
taken on day one when the possums were found dead in their 
cages and the second taken the following day. Possum tissue 
samples were analysed by Flinders Cook Ltd (Auckland) by 
extracting them into distilled water, centrifuging, filtering and 
determining nitrite by measuring azo dye colour development.
Possum carcasses were defrosted for each trial, after 
which they were skinned and either retained whole or the meat 
(flesh removed from carcasses around the spine and the front 
and back legs), vital organs (heart, liver, lungs and kidneys) 
and gut (stomach and intestines) were carefully removed and 
placed into separate buckets. The stomach was included as 
it may have higher levels of residue due to the possibility of 
any undigested toxic bait. By feeding dogs, cats and chickens 
whole carcasses as well as specific organs and gut we were 
able to evaluate different scenarios of animals scavenging 
entire carcasses or only specific organs.
Animals used in the dog and cat trials were either fed whole 
carcasses or different combinations of minced possum meat, 
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vital organs and gut. For the trials where possum carcasses 
were retained whole, carcasses were defrosted 2 days prior to 
that specific trial (to allow them to thaw) and kept in sacks in a 
fridge at 2°C. For trials where possum meat, vital organs and 
gut were fed to cats and dogs, possum carcasses were defrosted 
2 days prior to the trial. Meat, vital organs and gut were each 
minced separately in an industrial mincing machine to ensure 
no cross contamination of samples. The mincing machine was 
washed down between mincing meat, vital organs and gut. 
Once minced, the meat, vital organs and gut were weighed 
and equal amounts were allocated to individual trial animals. 
Allocated samples were then placed in individual snap-lock 
bags and kept in a fridge at 2°C until required during each trial. 
Eighty-six additional brushtail possums, not exposed 
to toxic baits, were used as an experimental control. These 
possums were captured using Victor® leg-hold traps in 
Hororata, Canterbury, New Zealand. Possums were killed by 
professional trappers who harvested the fur before supplying 
the carcasses which were then stored in a freezer at -10°C. 
For each trial, possums were defrosted, skinned and then fed 
to dogs, cats and chickens. Whole possum carcasses or the 
minced meat, vital organs and gut were fed to dogs, cats and 
chickens to acclimatise them to possum meat prior to the trial. 
The minced non-toxic possums were also fed to the control 
group in the dog, cat and chicken trials.
Dog secondary poisoning trial
Ten dogs of various breeds, seven males and three females, 
scheduled for euthanasia by the Christchurch pound were 
transported to the Pest-Tech Ltd. animal facility, Leeston, 
Canterbury. Their average weight was 23.62 kg (range 
19.75–30.40 kg). They were housed individually in cages 
constructed of wire mesh with a wooden kennel for shelter at 
one end and measured 250 cm x 150 cm x 80 cm. Dogs were 
fed, exercised and monitored daily with water available ad 
libitum. Dogs were fed a mixture of dog biscuits, sheep meat 
and dog roll – which is a commercially manufactured pet 
food product containing beef, chicken and lamb meat with 
vegetables and minerals. The animals were randomly divided 
into group one (n=4), group two (n=4) and group three (n=2). 
Groups one and two were both treatment groups, and group 
three acted as a control group. The feeding regime for the 
two treatment groups outlined below allowed us to evaluate 
the risk of secondary poisoning to dogs scavenging entire 
carcasses as well as specific organs. Group sizes were kept 
small in keeping with the ‘3Rs’ principles (Russell & Burch 
1959), namely the second of the 3Rs, reduction, which aims 
to use as few animals in trials as necessary. 
In the week before the trial commenced, animals in all three 
groups were fed non-toxic possum meat, to acclimatise them to 
the taste. Dogs in group one were each fed approximately 450 
g of minced possum meat for days one and two; approximately 
100 g of minced vital organs for days three and four; and 
approximately 375 g of minced gut for days five and six. Each 
dog received the equivalent of two whole possums. Dogs in 
group two were fed a single possum carcass on days one and 
two, and then two possum carcasses on day three. Dogs in 
group three were fed approximately 500 g made up of minced 
possum meat, vital organs and gut for six consecutive days; 
this was the equivalent of three whole possums per animal. 
Amounts fed to dogs were based on previous secondary 
poisoning studies in which possum carcasses were fed to dogs 
(Henderson et al. 2003; Henderson 2009).
Once the animals were well acclimatised to eating possum, 
then the trial commenced. The feeding regime and amounts fed 
for each of the three groups was identical to that used in the 
acclimatisation period the week prior to the trial. For groups 
one and two, the meat, vital organs, gut and whole possum 
carcasses were from possums poisoned with baits containing 
encapsulated NaNO2. Group one dogs were each fed minced 
possum meat for days one and two, minced vital organs for 
days three and four and minced gut for days five and six; each 
dog received the equivalent of two whole possums. Group two 
dogs were each fed a single possum carcass on days one and 
two, dog biscuits and dog roll on days three, four and five and 
then two possum carcasses on day six. Group three were each 
fed a combination of minced possum meat, vital organs and 
gut for 6 consecutive days sourced from possums caught in 
leg-hold traps. This was the equivalent of three whole possums 
per dog. The amounts fed to dogs and the length of the trial 
was based on previous VTA secondary poisoning trials that 
involved dogs being fed possum carcasses, meat, vital organs 
and gut (Henderson et al. 2003; Henderson 2009).
After each feeding, dogs were observed continuously for 
3 hours for signs of NaNO2 poisoning including vomiting, 
excessive thirst, diarrhoea, heavy panting, the loss of co-
ordination and methaemoglobinaemia (such as shortness of 
breath, cyanosis, lethargy, loss of consciousness, and bluish 
colouring of lips, gums, paws and nose). Each of the three 
trial groups was observed continuously by a single researcher 
standing within one metre of the wire cages and dogs within 
each group were observed simultaneously. The 3-hour 
observation period was chosen based on the known rapid 
absorption of NaNO2 and its rapid excretion as evidenced in 
its plasma elimination half-life (t1/2) of 30 minutes for dogs 
(Schneider & Yeary 1975).
Blood samples were taken on four occasions; an initial 
baseline sample prior to the trial, and three samples after each 
of the feeding sections of the trial on days one, two and six. 
Blood samples were taken between 30 to 60 minutes after 
individuals had finished feeding to ensure the best chance of 
detecting NaNO2. This sampling regime was based on previous 
research that reported rats orally dosed with NaNO2 experienced 
peak plasma concentrations 30 mins after dosing (MRI 2004).
Each blood sample was split into two collection vials. 
One standard vial was used to collect blood to be analysed for 
blood chemistry parameters. One heparinised vial was used 
to analyse haematology parameters including red blood cell 
counts and haemoglobin levels. Heparin prevents blood from 
coagulating and haematological measurements require whole 
uncoagulated blood (Lanning 2001). The baseline sample was 
taken 4 days prior to the toxic trial while dogs were being 
fed non-toxic possum meat to account for any effects of the 
possum meat on haematology and blood chemistry during 
the toxic trial. 
All dogs were euthanised by a veterinarian (in accordance 
with the pound’s original euthanasia plans for these animals) on 
day seven of the trial. Five tissue samples (skeletal muscle, liver, 
kidney, heart and lung tissue) were taken from each dog post 
mortem. These samples were stored in a 10% formalin solution 
prior to preparation for histological analysis. The histological 
analysis enabled the identification of any tissue damage that 
may have resulted from the potential ingestion of any NaNO2 
residues. The analysis of blood samples included haematology 
and blood chemistry. Analysis of blood samples focused on 
several parameters that are key indicators of liver, kidney and 
muscle health; these were of particular interest as they would 
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highlight any potential tissue damage that may have been 
caused. Levels of bilirubin, alanine aminotransferase (ALT) 
and aspartate aminotransferase (AST) are commonly measured 
as markers for liver health (Bush 1991). Toxic damage to the 
liver commonly results in elevated levels of these parameters 
(Bush 1991; Willard & Tvedten 2012). Abnormal levels of 
AST are also symptomatic of muscle tissue damage (Bush 
1991; Willard & Tvedten 2012). Phosphate and creatinine 
are commonly measured as markers for kidney health and 
abnormal levels can indicate renal damage (Bush 1991; Willard 
& Tvedten 2012). A reference range of ‘normal’ values for each 
of these parameters, as well as key haematology parameters 
including red blood cell and haemoglobin levels, has been 
generated by Gribbles Veterinary Pathology New Zealand for 
diagnostic purposes and are supplied with diagnostic tests. 
The values of these key parameters recorded for animals in 
the trial were compared to the reference range to determine 
if there were any adverse effects from consuming carcasses 
of possums poisoned with encapsulated NaNO2. 
Cat secondary poisoning trial
Ten feral cats were captured from the wild and transported 
to the Pest-Tech Ltd. animal facility. They were housed 
individually and cages contained a tray with sand to act as a 
latrine and a box with bedding for them to sleep in. Cages were 
constructed of steel mesh and measured 110 cm × 55 cm × 60 
cm. Cats were fed daily with water available ad libitum. The 
average weight was 3.095 kg (range 2.150–4.128 kg). They 
were fed a mixture of cat biscuits and beef meat. Feral cats 
were randomly divided into three groups identical in sample 
size to those used for the dogs.
In the week before the trial commenced, all three groups 
were fed non-toxic possum meat to acclimatise them to the 
taste. Feeding in this stage of the trial was identical to that 
undertaken for the dog trial in terms of the feeding regime and 
amounts fed. There was one difference, group two were each 
fed a single possum carcass on days one, three and five and 
this was done due to the difference in size and consumption 
rates between cats and dogs. 
Once all animals were well acclimatised to eating possums, 
the trial commenced. The feeding regime for all three groups 
was identical to that used in the acclimatisation period the week 
prior to the trial. The meat, vital organs and gut fed to group 
one and the whole possum carcasses fed to group two were 
from possums poisoned with baits containing encapsulated 
NaNO2. Group three, the control group, was fed non-toxic 
possum meat, vital organs and gut sourced from possums 
caught in leg-hold traps. On each occasion after cats were 
fed they were observed continuously for 3 hours for signs 
of NaNO2 poisoning including vomiting, excessive thirst, 
diarrhoea, difficulty breathing, the loss of co-ordination and 
methaemoglobinaemia. 
All cats were euthanised by a veterinarian on day seven of 
the trial and a blood sample and five tissue samples (skeletal 
muscle, liver, kidney, heart and lung tissue) were taken from 
each cat post mortem. Due to the difficulty in obtaining blood 
samples from feral cats this was the only sample taken and it 
was collected and analysed following the same procedure as 
those taken for dogs. The tissue samples were stored in a 10% 
formalin solution prior to preparation for histological analysis. 
Bird secondary poisoning trial
Ten chickens (brown shavers) were purchased from commercial 
breeders and transported to the Johnston Memorial Laboratory, 
Lincoln University. The average weight was 1.907 kg (range 
1.652–2.368 kg). They were housed individually in outdoor 
enclosures constructed of plywood and wire mesh and 
measuring 200 cm × 150 cm × 150 cm. Chickens were fed 
daily and water was available ad libitum. Chickens were split 
into group one (n=8) and group two (n=2). In the week before 
the toxic trial commenced, chickens in both groups were fed 
non-toxic possum meat to acclimatise them to the taste. Group 
one was fed approximately 200 g of minced possum meat 
for days one and two, approximately 50 g of minced vital 
organs for days three and four and approximately 100 g of 
minced gut for days five and six. Each individual received the 
equivalent of one and a half whole possums. Group two was 
fed approximately 200 g each day made up of a combination 
of minced possum meat, vital organs and gut for 6 consecutive 
days; this was the equivalent of one and a half whole possums 
per chicken.
Once all animals were well acclimatised to eating possum, 
the trial commenced. Group one chickens were each fed possum 
meat, vital organs and gut from possums poisoned with baits 
containing NaNO2 and group two chickens, the control group, 
were each fed non-toxic possum meat, vital organs and gut all 
combined and sourced from possums caught in leg-hold traps. 
During the toxic section of the trial, the feeding regime 
and amounts fed were identical to the acclimatisation period 
and the trial ran for 7 days. On each occasion after chickens 
were fed they were observed continuously for 3 hours for 
signs of NaNO2 poisoning including difficulty breathing, 
excessive thirst, diarrhoea, the loss of co-ordination and 
methaemoglobinaemia (such as shortness of breath, cyanosis, 
lethargy, loss of consciousness and bluish colouring inside the 
beak). Each of the trial groups was observed continuously by 
a single researcher standing within one metre of the enclosures 
and chickens within each group were observed simultaneously. 
On day seven all chickens were euthanised using CO2, but no 
blood or tissue was taken.
Veterinarians from Selwyn-Rakaia Veterinary Services 
took blood and tissue samples from cats and dogs in each 
trial and also euthanised all cats and dogs with pentobarbital 
at the conclusion of each trial. Analysis of blood samples 
was undertaken by Gribbles Veterinary Pathology, Dunedin, 
and tissue samples were analysed by Gribbles Veterinary 
Pathology, Christchurch. 
All animal manipulations were approved by the Lincoln 
University Animal Ethics Committee (AEC approvals 236, 
369, 370 and 371). Statistical analysis was done using Genstat 
version 15. The mean results of the blood chemistry and 
haematology for each treatment group of dogs were compared 
using repeated-measures ANOVA. The same analysis was 
carried out for each treatment group of cats using a one-way 
ANOVA.
Results
None of the dogs, cats or chickens involved in the three 
trials displayed any obvious physiological signs of 
methaemoglobinaemia as a result of eating carcasses, minced 
meat, vital organs or stomach of possums poisoned with 
encapsulated NaNO2. Additionally, in the blood samples taken 
from all dogs, there were no significant differences (P > 0.2) 
in the haematology (Figs. 1a & 1b) or blood chemistry (Figs. 
1c, 1d, 1e, 1f & 1g) between treatment and control groups. 
No changes in histology relating to NaNO2 intoxication were 









































































































































Figure 1. The average (a) haemoglobin (b) red blood cell counts 
and blood serum concentrations of: (c) bilirubin, (d) creatinine 
(e) AST, (f) ALT and (g) phosphate of dogs in group one (●―●), 
group two (■―■), the control group (▲―▲) and the upper 
and lower levels of the reference range (- - - - -). Error bars are 
standard errors of the mean.
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The histology of heart, liver, lungs, kidney and skeletal 
muscle tissue from each dog reported no changes relating to 
NaNO2 intoxication for any of the study dogs.
Of the blood chemistry and haematology parameters 
measured, only ALT, AST and phosphate recorded values 
outside the reference range. A power analysis carried out for 
each of these three parameters showed the following. For AST 
levels recorded in dogs on day three the variance between 
group means was 18.75 IU I-1 and the power was 0.338. To 
run a test with an appropriate level of power (i.e. β=0.8) we 
would need 14 dogs in each treatment group. 
For ALT levels recorded in dogs on day six the variance 
between group means was 46.50 IU I-1 and the power was 
0.157. To run a test with an appropriate level of power (i.e. 
β=0.8) we would need 41 dogs in each treatment group.
For phosphate levels recorded in dogs on day three the 
variance between group means was 0.86 mmol L-1 and the 
power was 0.954. To run a test with an appropriate level of 
power (i.e. β=0.8) we would need four dogs in each treatment 
group. This was the actual sample size and indicates that the 
statistical test had sufficient power to detect any differences.
Cats
No signs of methaemoglobinaemia were observed in any of 
the cats over the entire study; however, all four cats in group 
one refused to eat the minced possum gut over the 2 days 
these were presented. In group two, one cat refused to eat any 
of the whole possum carcasses presented to it, while another 
consumed two possum carcasses, and two cats consumed 
approximately 75% of a single possum carcass each. 
Despite some differences between groups of cats for the 
levels of bilirubin and creatinine, they were within the ‘normal’ 
reference range for all cats for the blood samples taken at the 
conclusion of the trial. There was no significant difference 
between treatment groups for levels of bilirubin (F(2,7)=1.24, P 
= 0.346). Levels of creatinine in individuals in group one were 
significantly higher (F(2,7)=9.43, P = 0.01) than those of group 
two and the control group. However, the 2 days between blood 
collection and serum separation at the laboratory artificially 
elevated the phosphate, ALT and AST levels as well as the 
red blood cell and haemoglobin levels for all of the cats and 
so these parameters of the blood chemistry and haematology 
were not included in the formal analysis. The histology of 
heart, liver, lungs, kidney and skeletal muscle tissue showed 
no changes of significance for any of the study cats.
Birds
No signs of methaemoglobinaemia were observed in any of 
the chickens over the entire study. Chickens consumed all 
of the minced possum meat, vital organs and stomach fed to 
them (apart from two chickens that only consumed 50% of 
their minced possum gut on day six). These two chickens then 
resumed eating their standard grain feed on day seven when 
the trial had concluded. 
Discussion
The results of this study indicate there is no, or at worst a very 
low, risk of secondary poisoning for dogs, cats and birds that 
eat the carcasses and/or vital organs of possums poisoned with 
baits containing 10% NaNO2. The results indicating a lack of 
secondary poisoning risk are consistent with the relatively low 
observed in dogs or cats after being fed carcasses, minced meat, 
vital organs or stomachs of possums poisoned with NaNO2. 
Analysis of tissue samples taken from two possums 
poisoned with paste bait containing encapsulated NaNO2 
detected very low levels of NaNO2 residue (≤5 mg kg-1) present 
in the muscle and stomach samples from both possums on day 
one but no residues were detected from either possum on day 
two. No NaNO2 residues were detected in liver samples from 
either possum on days one or two.
Dogs
No signs of methaemoglobinaemia were observed in any of 
the dogs over the course of the study. After dogs in group two 
were each fed two carcasses, dogs were observed as slightly 
subdued approximately 30 to 60 minutes after consuming the 
carcasses, although no obvious signs of methaemoglobinaemia 
(blue tongue or gums) were observed in any of the dogs. One 
dog, in group two, was observed regurgitating a small portion 
of possum carcass fed on days two and seven. On each occasion 
the dog proceeded to eat the regurgitated material without 
further untoward effects or any aversion. 
The haemoglobin (Figure 1a) and red blood cell (Figure 
1b) levels were within the ‘normal’ reference range for all 
dogs for the four sets of blood samples taken. There was 
a significant change over time for levels of haemoglobin 
(F(3,20)=1.07, P = 0.013). However, there was no significant 
time × group interaction (F(6,20)=2.93, P = 0.081). There was 
also no significant difference between treatment groups for 
haemoglobin (F(2,7)=0.46, P = 0.647).
There was no significant change in the mean RBC over the 
length of the trial (F(3,20)=1.07, P = 0.372). There was also no 
significant difference between treatment groups for the RBC 
(F(2,7)= 0.03, P = 0.974).
In the blood chemistry of all dogs in the trial there was no 
significant change over time for levels of bilirubin (F(3,21)=2.32, 
P = 0.137) or for levels of creatinine (F(3,21)=4.05, P = 0.051) 
and no significant difference between treatment groups for 
bilirubin (F(2,7)=0.53, P = 0.608) or creatinine (F(2,7)=0.65, 
P = 0.551).
There was a significant change over time for the levels 
of AST (F(3,21)=21.83, P < 0.001). However, there was no 
significant time × group interaction (F(6,21)=1.31, P = 0.314) 
and no significant difference (F(2,7)=0.01, P = 0.993) between 
treatment groups. A total of 40 blood samples were taken from 
the 10 dogs in the three treatment groups, only eight of these 
were within the reference range for AST. Only one of the 
eight blood samples taken from the two non-treatment dogs 
was within the reference range, AST levels were elevated for 
dogs in all three groups prior to and during the trial.  
The levels of ALT were within the ‘normal’ reference 
range for all values except for group two that recorded an 
elevated mean level on day six (Fig. 1f). This was due to one 
of the dogs in that group recording an ALT level of 268 IU L-1 
while the other three dogs recorded levels between 27 to 46 
IU L-1. There was no significant change over time for levels 
of ALT (F(3,21)=1.03, P = 0.346). There was also no significant 
difference between treatment groups (F(2,7)=0.13, P = 0.883).
There was a significant change in the mean levels of 
phosphate over the length of the trial (F(3,21)=290.45, P < 0.001) 
and this was most likely due to the mildly elevated levels of 
phosphate in all three groups on day three. However, there 
was no significant time × group interaction (F(6,21)=2.18, P = 
0.153) and no significant difference between treatment groups 
(F(2,7)=1.78, P = 0.237).
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acute toxicity of NaNO2 versus other vertebrate toxic agents 
and the rapid excretion of NaNO2 (Kohn et al. 2002; MRI 
2004). The LD50 for NaNO2 in possums is approximately 121.6 
mg kg-1 (95% CI 45.36–169.6 mg kg-1) (Shapiro et al. 2016) 
compared to 1.2 mg kg-1 for 1080 in possums (Eason et al. 
2011). As well as no obvious signs of methaemoglobinaemia 
being observed in dogs, cats or chickens, the blood chemistry 
parameters analysed for dogs and cats indicated that after they 
consumed possum carcasses their liver and renal function 
remained normal and there was no damage to muscle tissue. 
The use of animals in research is strictly governed by 
ethics and the desire to keep group sizes as small as possible. 
The research reported here was no different; however, when 
the response is variable (within groups) statistical power can 
be compromised. For our analysis there is concern regarding 
recorded values outside of the reference range, namely for 
ALT, AST and phosphate. 
For phosphate levels, the power analysis indicated that 
the sample size of four still provided high statistical power 
when analysing the results for day five. This analysis suggests 
that the elevated levels of phosphate at this time point were 
unlikely to be different to the control group.
For both ALT and AST, a power analysis indicated a low 
statistical power between the treatment and control groups 
with the sample sizes used. Certainly this warrants comment; 
however, only one dog in group two recorded an abnormally 
high level of ALT and this was on day six, all other dogs were 
within the reference range parameters at each time point. This 
dog had consumed two whole possum carcasses although it 
displayed no obvious signs of NaNO2 poisoning or symptoms 
of methaemoglobinaemia. Also, on day six the haematology 
parameters and the other blood chemistry parameters for this 
dog were all within the ‘normal’ reference range. It was not 
the dog in group two that was observed regurgitating a small 
portion of possum carcass. 
Additionally, the AST levels were elevated for all 10 
dogs prior to and during the trial and to redo this experiment 
with acceptable statistical power we would need 14 dogs 
for each treatment group. Despite the low level of statistical 
power future trial work is not warranted given that there 
were no obvious signs of NaNO2 poisoning and symptoms 
of methaemoglobinaemia observed in any of the dogs. Also, 
the histology of heart, liver, lungs, kidney and skeletal muscle 
tissue from each dog reported no changes relating to NaNO2 
intoxication. 
NaNO2 is rapidly eliminated from the blood of both rats 
and mice. In rats orally dosed with 80 mg kg-1, peak plasma 
concentrations were achieved at 30 mins after dosing and 
these decreased to below the limit of detection after 8 hours 
(MRI 2004). In mice, peak plasma concentrations occurred 
after 10 minutes and NaNO2 was undetectable in the blood 
after 4 hours. The pharmacokinetic data on NaNO2 in such 
diverse species as mice, rats, sheep, dogs, horses and humans 
(Schneider & Yeary 1975; Kohn et al. 2002), coupled with 
information on the toxicodynamics of NaNO2, suggests that 
a considerable amount of the NaNO2 ingested by a possum 
is likely to be excreted prior to death, even though death is 
comparatively rapid. 
The toxicokinetics and toxicodynamics of NaNO2 led us to 
feel reasonably confident that the secondary poisoning risk of 
NaNO2 would be low and this has now been verified. The low 
risk of secondary poisoning for dogs, cats and birds that eat 
possum carcasses which contain NaNO2 residues is comparable 
to cholecalciferol, which also has low secondary poisoning 
risk for dogs and cats (Eason et al. 2000) and cyanide which 
has no secondary poisoning risk (Gregory et al.1998). This 
outcome is in contrast with 1080, where the risk of secondary 
poisoning for dogs that eat possum carcasses poisoned with 
1080 is high (Meenken & Booth 1997; Eason et al. 2014), 
and brodifacoum which can accumulate and cause secondary 
poisoning (Litten et al. 2002).
The low secondary poisoning risk from carcasses of 
possums poisoned with NaNO2, combined with an effective 
antidote for primary poisoning and its effectiveness for killing 
possums (Shapiro et al. 2016) and feral pigs (Shapiro et al. 
2015) gave us confidence in pursuing registration of NaNO2 
baits for possum and feral pig control. 
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